STUDIES OF POSTOPERATIVE ADJUVANT CHEMOTHERAPY BASED ON THE PREDICTION OF EFFICACY OF 5-FU-BASED CHEMOTHERAPY FOR GASTRIC CANCER.
| Project/Area Number |
12671199
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | CHIBA UNIVERSITY |
|---|
Principal Investigator |
NABEYA Yoshihiro (2002-2003) CHIBA UNIVERSITY, GRADUATE SCHOOL OF MEDICINE, ASSISTANT, 大学院・医学研究院, 助手 (40322028)
鈴木 孝雄 (2000-2001) 千葉大学, 大学院・医学研究院, 助教授 (90235961)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SHIMADA Hideaki CHIBA UNIVERSITY, GRADUATE SCHOOL OF MEDICINE, LECTURER, 大学院・医学研究院, 講師 (20292691)
GUNJI Yoshio CHIBA UNIVERSITY, GRADUATE SCHOOL OF MEDICINE, ASSOCIATE PROFESSOR, 大学院・医学研究院, 助教授 (60241957)
OCHIAI Takenori CHIBA UNIVERSITY, GRADUATE SCHOOL OF MEDICINE, PROFESSOR, 大学院・医学研究院, 教授 (80114255)
MATSUBARA Hisahiro CHIBA UNIVERSITY, GRADUATE SCHOOL OF MEDICINE, LECTURER, 大学院・医学研究院, 講師 (20282486)
鍋谷 圭宏 千葉大学, 医学部・附属病院, 助手 (40322028)
|
|---|
| Project Period (FY) |
2000 – 2003
|
| Project Status |
Completed (Fiscal Year 2003)
|
| Budget Amount *help |
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 2003: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2002: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2001: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2000: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
|---|
| Keywords | 5-FU / thymidylate synthase (TS) / dihydropyrimidine dehydrogenase (DPD) / thymidine phosphorylase (TP) / GASTRIC CANCER / HISTOLOGICAL EFFECT / DRUG SENSITIVITY / p53 / Thymidylate synthase (TS) / TS阻害率 / Dihydropyrimidine dehydrogenase (DPD) / Thymidine phosphorylase (TP) / mRNA / TS / DPD / thymidylate synthase(TS) / dehydropyrimidine dehydrogenase(DPD) / 抗癌剤感受性試験 |
|---|
| Research Abstract |
[Purpose and methods] The tumoral activity of thymidylate synthase (TS) or dihydropyrimidine dehydrogenase (DPD), the metabolizing enzyme of 5-fluorouracil (5-FU), has reportedly been related to either the sensitivity to 5-FU or the prognosis of the patient. However, possible changes in the activity of such 5-FU-metabolizing enzymes resulting from an exposure of cancer cells to 5-FU may also affect the cellular response to 5-FU. In the present study, we measured the tumoral mRNA expressions of TS/DPD in gastric cancer patients before and after preoperative chemotherapy with UFT (comprising 5-FU prodrug tegafur and uracil at a ratio of 1:4), and aimed to clarify whether such TS/DPD mRNA expression levels could be correlated with the histological efficacy of UFT. In another experimental study, we examined possible perturbations in the activity of 5-FU-metabolizing enzymes during an exposure of gastric cancer cells to 5-FU, and the association with sensitivity to 5-FU was investigated. [Results] The tumoral TS and DPD levels were found to be altered by 5-FU treatment in both of gastric cancer patients and cultured gastric cancer cells. In the clinical study, the low DPD mRNA level before administration of UFT correlated with the favorable histological effect, while the TS mRNA level did not correlate with the histological effect in each case. In the experimental study, either elevation of TS total/inhibition rate or low level of DPD during 5-FU exposure was associated with sensitivity to 5-FU in cultured gastric cancer cells. [Significance] The different alterations in the TS and DPD levels induced by 5-FU exposure may be a critical response defining the sensitivity or resistance for 5-FU in gastric cancer cells, while the molecular mechanisms of such alterations have yet to be elucidated.
|
Report
(5 results)
Research Products
(2 results)
